About Tesalys
Tesalys is a company based in Toulouse (France) founded in 2012 by Miquel Lozano and Jean-Michel Rodriguez. Tesalys has raised $8.2 million across 2 funding rounds from investors including IXO, Sigma Gestion and Entrepreneur Venture. Tesalys offers products and services including STERIPLUS™, STERISHRED®, and Tesatruck. Tesalys operates in a competitive market with competitors including RxDestruct, Biotic Waste, Sterilissolutions, Alexander International Innovations and Rotoblock, among others.
- Headquarter Toulouse, France
- Founders Miquel Lozano, Jean-Michel Rodriguez
-
Sectors
Environment
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.2 M (USD)
in 2 rounds
-
Latest Funding Round
$6.84 M (USD), Series A
Jan 28, 2019
-
Investors
IXO
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tesalys
Tesalys offers a comprehensive portfolio of products and services, including STERIPLUS™, STERISHRED®, and Tesatruck.
Grinds and disinfects infectious waste using steam sterilization technology.
Shreds and decontaminates medical waste for safe disposal.
Provides mobile system for on-site infectious waste treatment.
People of Tesalys
Unlock access to complete
Unlock access to complete
Funding Insights of Tesalys
Tesalys has successfully raised a total of $8.2M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.84 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Tesalys
Tesalys has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include IXO, Sigma Gestion and Entrepreneur Venture.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments in France are managed by IXO.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Tesalys
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tesalys
Investment portfolio details for Tesalys
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tesalys
Detailed financials for Tesalys
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tesalys Comparisons
Peer comparison for Tesalys
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tesalys
Tesalys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RxDestruct, Biotic Waste, Sterilissolutions, Alexander International Innovations and Rotoblock, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Opioid medical waste is destroyed for healthcare facilities.
|
|
| Locked | Locked | Locked |
Provides biomedical waste collection, treatment, and disposal services for facilities.
|
|
| Locked | Locked | Locked |
On-site medical waste is converted to harmless material for disposal.
|
|
| Locked | Locked | Locked |
Medical devices for waste disposal in plasma-derived medications are developed.
|
|
| Locked | Locked | Locked |
Bio-hazardous waste incinerators are manufactured using heat, pressure, and steam.
|
Detailed competitors of Tesalys
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tesalys
Complete news archive for Tesalys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tesalys
Tesalys was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Tesalys is headquartered in Toulouse, France. It is registered at Toulouse, Occitanie, France.
Tesalys is a funded company, having raised a total of $8.2M across 2 funding rounds to date.
Treatment solutions for infectious medical waste. It provides solutions to decontaminate bio-medical infectious waste using steam.
Tesalys's top competitors include RxDestruct, Rotoblock and Alexander International Innovations.
Tesalys offers STERIPLUS™, STERISHRED®, and Tesatruck.
Tesalys has 3 investors. Key investors include IXO, Sigma Gestion, and Entrepreneur Venture.